Should people with severe mental illness be prioritized for the COVID-19 vaccination?
COVID-19, severe mental illness
vaccination
Journal
International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
01
2021
accepted:
22
02
2021
entrez:
28
4
2021
pubmed:
29
4
2021
medline:
21
5
2021
Statut:
epublish
Résumé
The coronavirus disease-19 (COVID-19) has spread throughout the world, affecting many vulnerable populations including patients with severe mental illness (SMI). Recent studies have found that patients with SMI compared to the general population could have a greater risk of morbidity and mortality from COVID-19 due to cognitive impairment, poor awareness of risk, and difficulties in complying with infection control measures. Although some researchers have suggested that patients with SMI should be prioritized for COVID-19 vaccination to reduce the risk of infection, this issue remains controversial.
Identifiants
pubmed: 33907507
doi: 10.7150/ijbs.57750
pii: ijbsv17p1443
pmc: PMC8071759
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Editorial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1443-1445Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Front Psychiatry. 2019 Mar 20;10:131
pubmed: 30949074
World Psychiatry. 2021 Feb;20(1):54-55
pubmed: 33131217
Int J Biol Sci. 2020 Mar 15;16(10):1741-1744
pubmed: 32226293